Emyria Limited announced that Dr. Alistair Vickery has retired from the Board and will shift his expertise from Board responsibilities to concentrate on clinical service expansion, particularly as Emyria advances its MDMA-assisted therapy programs. Dr. Stewart Washer will move to Non-Executive Chairman from Executive Chairman and his salary will move from $200,000 per annum to a total fee of $80,000 per annum and; Dr. Karen Smith to Non-Executive Director with a salary in line with all current Non-Executive Directors. All changes are effective immediately.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.049 AUD | -3.92% | -12.50% | -5.77% |
Apr. 23 | Emyria to Raise AU$2.3 Million via Placement | MT |
Apr. 10 | Emyria Launches Empax Center | MT |
1st Jan change | Capi. | |
---|---|---|
-5.77% | 11.72M | |
-20.16% | 16.21B | |
+4.50% | 12.44B | |
+3.98% | 11.58B | |
+9.72% | 10.79B | |
+23.61% | 8.26B | |
-2.19% | 7.68B | |
+20.75% | 7.2B | |
+4.49% | 6.67B | |
+50.89% | 4.66B |
- Stock Market
- Equities
- EMD Stock
- News Emyria Limited
- Emyria Limited Announces Board Changes